Mike Famulare

Sr. Research Scientist

Mike Famulare

Sr. Research Scientist


Mike Famulare is a Senior Research Scientist at the Institute for Disease Modeling (IDM) in Bellevue, WA, where he uses mathematical modeling to study infectious disease transmission and surveillance. Since joining IDM, he has worked closely with partners in the Global Polio Eradication Initiative to assess the impacts of polio vaccination policies on poliovirus transmission in different settings. He also conducts research on the design and interpretation of genomic and environmental surveillance data for infectious diseases. He has a PhD in Physics from the University of Washington, where he focused on adaptive single neuron computation. Before moving to Seattle, he earned a BS in Physics Education from New York University and taught briefly at Stuyvesant High School.

Biography

Mike Famulare is a Senior Research Scientist at the Institute for Disease Modeling (IDM) in Bellevue, WA, where he uses mathematical modeling to study infectious disease transmission and surveillance. Since joining IDM, he has worked closely with partners in the Global Polio Eradication Initiative to assess the impacts of polio vaccination policies on poliovirus transmission in different settings. He also conducts research on the design and interpretation of genomic and environmental surveillance data for infectious diseases. He has a PhD in Physics from the University of Washington, where he focused on adaptive single neuron computation. Before moving to Seattle, he earned a BS in Physics Education from New York University and taught briefly at Stuyvesant High School.

Publications

Friday, September 8, 2017

We evaluated the global cessation of the type 2 oral polio vaccine by modeling pre- and post-cessation detection rates in order to identify anomalous detections that may indicate prolonged circulat

Read online
Wednesday, October 14, 2015
Outbreaks of cVDPV can occur due to the genetic instability of the OPV vaccine strains in populations that have low levels of immunity to poliovirus.
Read online
Friday, August 28, 2015
Nigeria may be the next country to achieve wild-type polio elimination. The most recent case of wild-type 1 (WPV1) in Nigeria occurred in July 2014.
Read online
Sunday, March 1, 2015
Widespread genetic sequencing of pathogens is changing the practice of epidemiology.
Read online